Valuation — not yet established
No valuation for Atrandi Biosciences is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($32.0M) and the funding record below are the closest available signals.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Atrandi Biosciences
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Feb 2025 | Later Stage VC (Series A) | $25.0M | ▮ | ▮ |
| Aug 2023 | Seed Round | $5.9M | ▮ | ▮ |
How Atrandi Biosciences's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Atrandi Biosciences, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- How much has Atrandi Biosciences raised?
- Atrandi Biosciences has raised $32.0M in total funding across 2 recorded rounds.
- When did Atrandi Biosciences last raise?
- Atrandi Biosciences last raised in Feb 2025 (Later Stage VC (Series A)), raising $25.0M.